Genetic diagnosis and cochlear implantation for patients with nonsyndromic hearing loss and enlarged vestibular aqueduct

R. Lai, P. Hu, F. Zhu, G. Zhu, R. Vivero, A. Peng, W. Wu, Z. Xiao, Xue Z Liu, D. Xie

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

Objective: To review the genotype and cochlear implantation outcome of patients with nonsyndromic hearing loss and enlarged vestibular aqueduct. Methods: Twenty-one Chinese children with nonsyndromic hearing loss and enlarged vestibular aqueduct underwent genetic examination. A DNA microarray was used to screen for the IVS7-2A>G and H723R mutations. Any DNA samples with one or none of the two mutant alleles were sequenced to detect other mutations in the SLC26A4 and FOXI1 genes. Results: Twelve SLC26A4 mutations were detected, including three novel mutations. The most common mutations detected were IVS7-2A>G and H723R. Twelve patients received cochlear implants, and subsequently demonstrated excellent speech perception. Conclusion: Three novel mutations were detected in Chinese patients with nonsyndromic hearing loss and enlarged vestibular aqueduct. The SLC26A4 mutation spectrum in the Chinese population is similar to that in other East Asian populations. Cochlear implantation is a safe and effective treatment in patients with enlarged vestibular aqueduct.

Original languageEnglish
Pages (from-to)349-355
Number of pages7
JournalJournal of Laryngology and Otology
Volume126
Issue number4
DOIs
StatePublished - Apr 1 2012

Fingerprint

Cochlear Implantation
Mutation
Speech Perception
Cochlear Implants
Enlarged Vestibular Aqueduct
Nonsyndromic Deafness
Oligonucleotide Array Sequence Analysis
Population
Alleles
Genotype
DNA
Genes

Keywords

  • Child
  • Cochlear Implantation
  • DNA Sequence Analysis
  • Hearing Loss, Sensorineural
  • Microarray Analysis
  • Vestibular Aqueduct

ASJC Scopus subject areas

  • Otorhinolaryngology

Cite this

Genetic diagnosis and cochlear implantation for patients with nonsyndromic hearing loss and enlarged vestibular aqueduct. / Lai, R.; Hu, P.; Zhu, F.; Zhu, G.; Vivero, R.; Peng, A.; Wu, W.; Xiao, Z.; Liu, Xue Z; Xie, D.

In: Journal of Laryngology and Otology, Vol. 126, No. 4, 01.04.2012, p. 349-355.

Research output: Contribution to journalArticle

Lai, R. ; Hu, P. ; Zhu, F. ; Zhu, G. ; Vivero, R. ; Peng, A. ; Wu, W. ; Xiao, Z. ; Liu, Xue Z ; Xie, D. / Genetic diagnosis and cochlear implantation for patients with nonsyndromic hearing loss and enlarged vestibular aqueduct. In: Journal of Laryngology and Otology. 2012 ; Vol. 126, No. 4. pp. 349-355.
@article{da7b3deb942b45ae8a7c2e043a4cd56b,
title = "Genetic diagnosis and cochlear implantation for patients with nonsyndromic hearing loss and enlarged vestibular aqueduct",
abstract = "Objective: To review the genotype and cochlear implantation outcome of patients with nonsyndromic hearing loss and enlarged vestibular aqueduct. Methods: Twenty-one Chinese children with nonsyndromic hearing loss and enlarged vestibular aqueduct underwent genetic examination. A DNA microarray was used to screen for the IVS7-2A>G and H723R mutations. Any DNA samples with one or none of the two mutant alleles were sequenced to detect other mutations in the SLC26A4 and FOXI1 genes. Results: Twelve SLC26A4 mutations were detected, including three novel mutations. The most common mutations detected were IVS7-2A>G and H723R. Twelve patients received cochlear implants, and subsequently demonstrated excellent speech perception. Conclusion: Three novel mutations were detected in Chinese patients with nonsyndromic hearing loss and enlarged vestibular aqueduct. The SLC26A4 mutation spectrum in the Chinese population is similar to that in other East Asian populations. Cochlear implantation is a safe and effective treatment in patients with enlarged vestibular aqueduct.",
keywords = "Child, Cochlear Implantation, DNA Sequence Analysis, Hearing Loss, Sensorineural, Microarray Analysis, Vestibular Aqueduct",
author = "R. Lai and P. Hu and F. Zhu and G. Zhu and R. Vivero and A. Peng and W. Wu and Z. Xiao and Liu, {Xue Z} and D. Xie",
year = "2012",
month = "4",
day = "1",
doi = "10.1017/S002221511100346X",
language = "English",
volume = "126",
pages = "349--355",
journal = "Journal of Laryngology and Otology",
issn = "0022-2151",
publisher = "Cambridge University Press",
number = "4",

}

TY - JOUR

T1 - Genetic diagnosis and cochlear implantation for patients with nonsyndromic hearing loss and enlarged vestibular aqueduct

AU - Lai, R.

AU - Hu, P.

AU - Zhu, F.

AU - Zhu, G.

AU - Vivero, R.

AU - Peng, A.

AU - Wu, W.

AU - Xiao, Z.

AU - Liu, Xue Z

AU - Xie, D.

PY - 2012/4/1

Y1 - 2012/4/1

N2 - Objective: To review the genotype and cochlear implantation outcome of patients with nonsyndromic hearing loss and enlarged vestibular aqueduct. Methods: Twenty-one Chinese children with nonsyndromic hearing loss and enlarged vestibular aqueduct underwent genetic examination. A DNA microarray was used to screen for the IVS7-2A>G and H723R mutations. Any DNA samples with one or none of the two mutant alleles were sequenced to detect other mutations in the SLC26A4 and FOXI1 genes. Results: Twelve SLC26A4 mutations were detected, including three novel mutations. The most common mutations detected were IVS7-2A>G and H723R. Twelve patients received cochlear implants, and subsequently demonstrated excellent speech perception. Conclusion: Three novel mutations were detected in Chinese patients with nonsyndromic hearing loss and enlarged vestibular aqueduct. The SLC26A4 mutation spectrum in the Chinese population is similar to that in other East Asian populations. Cochlear implantation is a safe and effective treatment in patients with enlarged vestibular aqueduct.

AB - Objective: To review the genotype and cochlear implantation outcome of patients with nonsyndromic hearing loss and enlarged vestibular aqueduct. Methods: Twenty-one Chinese children with nonsyndromic hearing loss and enlarged vestibular aqueduct underwent genetic examination. A DNA microarray was used to screen for the IVS7-2A>G and H723R mutations. Any DNA samples with one or none of the two mutant alleles were sequenced to detect other mutations in the SLC26A4 and FOXI1 genes. Results: Twelve SLC26A4 mutations were detected, including three novel mutations. The most common mutations detected were IVS7-2A>G and H723R. Twelve patients received cochlear implants, and subsequently demonstrated excellent speech perception. Conclusion: Three novel mutations were detected in Chinese patients with nonsyndromic hearing loss and enlarged vestibular aqueduct. The SLC26A4 mutation spectrum in the Chinese population is similar to that in other East Asian populations. Cochlear implantation is a safe and effective treatment in patients with enlarged vestibular aqueduct.

KW - Child

KW - Cochlear Implantation

KW - DNA Sequence Analysis

KW - Hearing Loss, Sensorineural

KW - Microarray Analysis

KW - Vestibular Aqueduct

UR - http://www.scopus.com/inward/record.url?scp=84859128439&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84859128439&partnerID=8YFLogxK

U2 - 10.1017/S002221511100346X

DO - 10.1017/S002221511100346X

M3 - Article

C2 - 22289209

AN - SCOPUS:84859128439

VL - 126

SP - 349

EP - 355

JO - Journal of Laryngology and Otology

JF - Journal of Laryngology and Otology

SN - 0022-2151

IS - 4

ER -